117 CHANGES IN SYSTEMIC ANTIBODY EPITOPE REPERTOIRES FROM PRECLINICAL TO ESTABLISHED INFLAMMATORY BOWEL DISEASE

Tu1526 IL-37 COMBINED WITH IL-22 COULD SERVE AS A THERAPEUTIC STRATEGY FOR ACLF WITH THE EFFECT OF BOTH INHIBITING SYSTEMIC INFLAMMATION AND PROMOTING LIVER ...

Tu1270 CLINICAL PREDICTORS OF ESOPHAGEAL INVOLVEMENT IN SYSTEMIC SCLEROSIS

8 A LOW FAT, HIGH FIBER DIETARY INTERVENTION IN CROHN'S DISEASE (CD) PATIENTS IMPROVES SERUM PROTEOMIC AND METABOLOMIC PATTERNS REFLECTING IMPROVEMENTS ...